[1] |
Groszmann R J, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis[J]. N Engl J Med, 2005,353(21):2254-2261.
doi: 10.1056/NEJMoa044456
pmid: 16306522
|
[2] |
De Franchis R, Faculty B V. Expanding consensus in portal hypertension: report of the Baveno VI Consensus workshop: stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015,63(3):743-752.
doi: 10.1016/j.jhep.2015.05.022
pmid: 26047908
|
[3] |
徐小元, 丁惠国, 贾继东, 等. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 临床肝胆病杂志, 2016,32(2):203-208.
|
[4] |
Damico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review[J]. Hepatology, 1995,22(1):332-354.
pmid: 7601427
|
[5] |
Bhardwaj A, Kedarisetty C K, Vashishtha C, et al. Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial[J]. Gut, 2017,66(10):1838-1843.
pmid: 27298379
|
[6] |
Sarin S K, Mishra S R, Sharma P, et al. Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial[J]. Hepatol Int, 2013,7(1):248-256.
doi: 10.1007/s12072-012-9353-8
|
[7] |
Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding[J]. N Engl J Med, 2013,368(1):11-21.
pmid: 23281973
|
[8] |
Wells M, Chande N, Adams P, et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds[J]. Aliment Pharmacol Ther, 2012,35(11):1267-1278.
pmid: 22486630
|
[9] |
Seo Y S, Park S Y, Kim M Y, et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage[J]. Hepatology, 2014,60(3):954-963.
doi: 10.1002/hep.27006
|
[10] |
Puente A, Hernández-Gea V, Graupera I, et al. Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review[J]. Liver Int, 2014,34(6):823-833.
doi: 10.1111/liv.12452
|
[11] |
Mishra S R, Sharma B C, Kumar A, et al. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial[J]. J Hepatol, 2011,54(6):1161-1167.
doi: 10.1016/j.jhep.2010.09.031
pmid: 21145834
|
[12] |
El Amin H. A randomized trial of endoscopic variceal ligation versus cyanoacrylate injection for treatment of bleeding junctional varices[J]. Trop Gastroenterol, 2010,31(4):279-284.
pmid: 21568143
|
[13] |
Caldwell S. Gastric varices: is there a role for endoscopic cyanoacrylates, or are we entering the BRTO era?[J]. Am J Gastroenterol, 2012,107(12):1784-1790.
pmid: 23211846
|
[14] |
Mishra S R, Sharma B C, Kumar A, et al. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial[J]. Gut, 2010,59(6):729-735.
pmid: 20551457
|
[15] |
Hung H H, Chang C J, Hou M C, et al. Efficacy of non-selective beta-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial[J]. J Hepatol, 2012,56(5):1025-1032.
doi: 10.1016/j.jhep.2011.12.021
pmid: 22266602
|
[16] |
Leithead J A, Rajoriya N, Tehami N, et al. Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation[J]. Gut, 2015,64(7):1111-1119.
doi: 10.1136/gutjnl-2013-306502
pmid: 25281417
|